In Utero News and Research

RSS

Study reveals poor diet quality among pregnant and postpartum individuals

New research from the University of Massachusetts Amherst finds a pervasive low-quality diet among pregnant and postpartum individuals, reflecting "an urgent need for widespread improvement."

19 Dec 2024

Gut-targeted antidepressants: A novel approach to battling depression and anxiety

Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from "butterflies" in the stomach caused by nervousness to a loss of appetite when we're feeling blue.

11 Dec 2024

New insights into anti-seizure medications during pregnancy

Two common antiseizure medications, lamotrigine and levetiracetam, are safe to use during pregnancy, according to a Stanford Medicine-led study.

3 Dec 2024

Study links prenatal immune activity to Alzheimer's risk in later life

Findings from a Mass General Brigham-led study that has followed participants since before birth may offer clues about the origins of Alzheimer's disease.

21 Nov 2024

Study reveals slower fat gain in babies exposed to gestational diabetes

A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their first year of life.

20 Nov 2024

Antiseizure medications during pregnancy linked to neurodevelopmental risks in children

Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new data from researchers at Drexel's Dornsife School of Public Health.

15 Nov 2024

Prenatal cannabis exposure linked to increased risk of opioid addiction later in life

With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.

14 Nov 2024

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Research shows prenatal exposure to SARS-CoV-2 linked to slight regulatory behavior improvements in infants, but no significant neurodevelopmental impacts.

12 Nov 2024

Low-sugar diet in early life reduces risk of chronic diseases in adulthood

A low-sugar diet in utero and in the first two years of life can meaningfully reduce the risk of chronic diseases in adulthood, a new study has found, providing compelling new evidence of the lifelong health effects of early-life sugar consumption.

1 Nov 2024

1950’s sugar rationing policies reduced risks of hypertension and diabetes

The study links early-life sugar exposure to chronic disease risk, suggesting that sugar restriction could enhance health and reduce diabetes and hypertension.

31 Oct 2024

Elucidating the mechanisms behind kidney development

To Alex Hughes, Assistant Professor in Bioengineering within Penn Engineering and in Cell and Developmental Biology within Penn Medicine, the kidney is a work of art. "I find the development of the kidney to be a really beautiful process," says Hughes.

28 Oct 2024

Researchers create first single cell atlas of prenatal human skin

For the first time, researchers have created a single cell atlas of prenatal human skin to understand how skin forms, and what goes wrong in disease.

18 Oct 2024

A deeper look at COVID-19 transmission and fetal health

A new Cleveland Clinic-led study published in The EMBO Journal shows that mild and asymptomatic SARS-CoV-2 infections can trigger immune responses in a pregnant individual that may cause serious inflammatory responses in the developing fetus.

17 Oct 2024

Study shows no developmental delays in toddlers post-COVID-19 infection

Study explored the relationship between SARS-CoV-2 infection in children under two years old and cognitive development, finding no evidence of increased developmental delays post-infection. Differences in socioeconomic status were noted between COVID-19 positive and negative groups.

15 Oct 2024

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

Childhood obesity: How the first 2,000 days hold the key to lifelong health

Researchers reveal that early life factors, especially within the first 2,000 days, play a critical role in shaping future obesity risk. Addressing these factors with integrated interventions could combat the global childhood obesity crisis.

26 Sep 2024

Study shows no increased autism risk for pandemic-era children

Children born during the first year of the pandemic, including those exposed to COVID in utero, were no more likely to screen positive for autism than unexposed or pre-pandemic children, found researchers from Columbia University Vagelos College of Physicians and Surgeons.

23 Sep 2024